C. Hirashima

发表

Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy

T. Niki, C. Hirashima, M. Ogoyama, 2019, CEN Case Reports.

Independent risk factors for a small placenta and a small‐for‐gestational‐age infant at 35–41 weeks of gestation: An association with circulating angiogenesis‐related factor levels at 19–31 weeks of gestation

C. Hirashima, S. Matsubara, A. Ohkuchi, 2017, The journal of obstetrics and gynaecology research.

Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2011, Hypertension.

Additive effects of mean blood pressure and bilateral notching in the second trimester on subsequent angiogenesis-related factors

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2014, Hypertension Research.

Prediction of Early-Onset Preeclampsia Using Uterine Artery Doppler

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2014 .

Temporary hypertension and white coat hypertension in the first trimester as risk factors for preeclampsia

C. Hirashima, M. Ogoyama, S. Matsubara, 2019, Hypertension Research.

Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2011, Hypertension Research.

Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifially its expression at a low level in the second trimester and a high level after onset

C. Hirashima, M. Ogoyama, S. Matsubara, 2018, Hypertension Research.

A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2014, Hypertension Research.

Low placental growth factor levels and high soluble endoglin levels at 26–31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study

C. Hirashima, S. Matsubara, A. Ohkuchi, 2021, The journal of obstetrics and gynaecology research.

C-reactive protein levels at pre-/post-indicated cervical cerclage predict very preterm birth

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2011, Journal of perinatal medicine.

Prediction and prevention of hypertensive disorders of pregnancy

C. Hirashima, S. Matsubara, A. Ohkuchi, 2017, Hypertension Research.

Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant Women

Mitsuaki Suzuki, K. Kario, C. Hirashima, 2005, Hypertension Research.

Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia Are More Pronounced in Women with Early Onset Severe Preeclampsia

Mitsuaki Suzuki, K. Kario, C. Hirashima, 2007, Hypertension Research.

Antinuclear Antibody Reduces the Pregnancy Rate in the First IVF‐ET Treatment Cycle but Not the Cumulative Pregnancy Rate without Specific Medication

Mitsuaki Suzuki, C. Hirashima, H. Shibahara, 2003, American journal of reproductive immunology.

Alteration of Serum Soluble Endoglin Levels after the Onset of Preeclampsia Is More Pronounced in Women with Early-Onset

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2008, Hypertension Research.

Establishing reference values for mean notch depth index, pulsatility index and resistance index in the uterine artery at 16–23 weeks' gestation

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2012, The journal of obstetrics and gynaecology research.

Preeclamptic patient-derived circulating cell-free DNA activates the production of inflammatory cytokines via toll-like receptor 9 signalling in the human placenta.

C. Hirashima, A. Ohkuchi, K. Shirasuna, 2019, Journal of hypertension.

Difficulty of predicting early-onset super-imposed preeclampsia in pregnant women with hemodialysis due to diabetic nephropathy by serum levels of sFlt-1, PlGF, and sEng

C. Hirashima, A. Ohkuchi, K. Shirasuna, 2019, CEN Case Reports.

Increased serum levels of sFlt-1/PlGF ratio in preeclamptic women with onset at <32 weeks compared with ≥32 weeks.

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018, Pregnancy hypertension.

Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2010, Hypertension Research.

Serum sFlt1:PlGF Ratio, PlGF, and Soluble Endoglin Levels in Gestational Proteinuria

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2009, Hypertension in pregnancy.

Pregnancy outcomes in Japanese pregnant women with either chronic hypertension or white coat hypertension (JP-WCH): protocol for a prospective multicenter cohort study

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018 .

Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2014, CEN Case Reports.

Hydroxysteroid (17-&bgr;) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic Placentas: A Novel Marker for Predicting Preeclampsia

T. Takizawa, C. Hirashima, S. Matsubara, 2012, Hypertension.

Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization–embryo transfer

C. Hirashima, H. Shibahara, S. Takamizawa, 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Vaginal Ureaplasma species increase chorioamnionitis in very preterm infants with preterm premature rupture of the membranes at < 28 weeks of gestation

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2013, Hypertension Research.

Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy

Mitsuaki Suzuki, K. Kario, C. Hirashima, 2016, Journal of Human Hypertension.

Normal and High-Normal Blood Pressures, but Not Body Mass Index, Are Risk Factors for the Subsequent Occurrence of Both Preeclampsia and Gestational Hypertension: A Retrospective Cohort Study

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2006, Hypertension Research.

Vaginal Ureaplasma species increase chorioamnionitis in very preterm infants with preterm premature rupture of the membranes at < 28 weeks of gestation

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Mismatch between estimated blood loss and shock index in transferred women with postpartum hemorrhage

C. Hirashima, S. Matsubara, A. Ohkuchi, 2016 .

Markedly higher sFlt‐1/PlGF ratio in a woman with acute fatty liver of pregnancy compared with HELLP syndrome

C. Hirashima, M. Ogoyama, S. Matsubara, 2018, The journal of obstetrics and gynaecology research.

Video images: How to insert a Bakri balloon and hold the cervix

T. Kuwata, C. Hirashima, S. Matsubara, 2016 .

A trio of risk factors for the onset of preeclampsia in the second and early third trimesters.

Mitsuaki Suzuki, C. Hirashima, S. Matsubara, 2014, Pregnancy hypertension.

The Frequency of Peripheral Blood CD4+FoxP3+ Regulatory T Cells in Women With Pre-eclampsia and Those With High-risk Factors for Pre-eclampsia

S. Nishimura, C. Hirashima, S. Matsubara, 2015, Hypertension in pregnancy.

Serum soluble LIGHT in the early third trimester as a novel biomarker for predicting late-onset preeclampsia.

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018, Pregnancy hypertension.

Hydroxysteroid (17-&bgr;) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic Placentas: A Novel Marker for Predicting Preeclampsia

T. Takizawa, C. Hirashima, S. Matsubara, 2012, Hypertension.

A comparison of brand-name and generic versions of the anticoagulant, nafamostat mesilate, for hemodialysis

C. Hirashima, T. Nakanishi, M. Izumi, 2006 .